A. “Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression,” by Justin M. Drake, Nicholas A. Graham, Tanya Stoyanova, Amir Sedghi, Andrew S. Goldstein, Houjian Cai, Daniel A. Smith, Hong Zhang, Evangelia Komisopoulou, Jiaoti Huang, Thomas G. Graeber, and Owen N. Witte (Vol. 109, No. 5, Jan. 31, 2012, HTML and .pdf format, p. 1643-1648). This article is available free of charge.
www.pnas.org/content/109/5/1643.full
B. “Telomere length in early life predicts lifespan,” by Britt J. Heidinger, Jonathan D. Blount, Winnie Boner, Kate Griffiths, Neil B. Metcalfe, and Pat Monaghan Vol. 109, No. 5, Jan. 31, 2012, HTML and .pdf format, p. 1743-1748). This article is available free of charge.
www.pnas.org/content/109/5/1743.full
B. “Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases,” by Ferenc G. Rick, Andrew V. Schally, Luca Szalontay, Norman L. Block, Karoly Szepeshazi, Mehrdad Nadji, Marta Zarandi, Florian Hohla, Stefan Buchholz, and Stephan Seitz (Vol. 109, No. 5, Jan. 31, 2012, p. 1655-1660).
